Almitas Capital LLC 13D and 13G filings for AN2 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 9:58 pm Sale | 2026-03-31 | 13G | AN2 THERAPEUTICS INC ANTX | Almitas Capital LLC | 1,479,129 4.100% | -1,496,035 (-50.28%) | Filing |
| 2026-02-17 6:54 pm Purchase | 2025-12-31 | 13G | AN2 THERAPEUTICS INC ANTX | Almitas Capital LLC | 2,975,164 5.400% | 1,546,841 (+108.30%) | Filing |
| 2025-11-14 7:51 pm Purchase | 2025-09-30 | 13G | AN2 THERAPEUTICS INC ANTX | Almitas Capital LLC | 1,428,323 5.200% | 1,428,323 (New Position) | Filing |